ROOSEVELT INVESTMENT GROUP LLC Global Blood Therapeutics, Inc. Transaction History

ROOSEVELT INVESTMENT GROUP LLC portfolio value:

$10M
portfolio value

ROOSEVELT INVESTMENT GROUP LLC quarter portfolio value change:

+113.15%
quarter

Global Blood Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -81.70% -655.54K shares -15.63M $68.1 146.84K
Q2 2022 share Increase +34.44% 205.54K shares 4.96M $31.95 802.39K
Q1 2022 share Increase +43.24% 180.18K shares 8.47M $34.64 596.84K
Q4 2021 share Increase 0.00% 416.66K shares 12.19M $29.86 416.66K